Source 20240722_182808
Canonical Links
| item | link |
|---|
| Direct transcription | 20240722_182808 |
| Raw photo | data/raw/photos/20240722_182808.jpg |
| field | value |
|---|
| Page label | Page 446 of 453 |
| Navigation path | Pipeline of GD & GBA-PD > Supplement > Other Biobanks > Biobanks in Japan > BIOMARKER > BioOrchestra > Dose finding > Sample size calculation |
| Section | GBA-PD, GD, and α-Synuclein Pipeline |
| Uncertain spans | 3 |
| Embedded images | 0 |
| Related photos | 2 |
Headings
- C-Path SWEDD vs DAT-Deficient slide (Conrado 2018), Summary from below percentages, Description table (intervention-based suppression of disease progression), WATCH-PD sample-size narrative, 2017 Simuni Table 1, 2018 Marek Column A table, TAK-341 IDP / ePOC / GBA GT PRC1 / 20210122_RSLT_GBA GT v2_GP rows
- Rate of Motor Decline in SWEDD and DAT-Deficient Subjects was Different - Statistically and Clinically (slide)
- Summary from below
- 바람직한 description: x% (intervention-based) suppression (or reduction in) of disease progression (relative to placebo)
- Uncertain Spans
Wiki Coverage
Topic-level synthesis should link back to this source note or directly to the canonical transcription when making specific claims.